Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,329,000 | 7,067,000 | 15,567,000 | 7,636,000 | 7,832,000 |
| Marketable Securities | 69,000 | 82,000 | 62,000 | 129,000 | 160,000 |
| Inventories | 8,983,000 | 10,528,000 | 4,762,000 | 4,278,000 | 4,024,000 |
| Other current assets | 9,351,000 | 9,014,000 | 6,883,000 | 6,692,000 | 5,793,000 |
| TOTAL | $26,244,000 | $26,691,000 | $27,274,000 | $18,735,000 | $19,544,000 |
| Non-Current Assets | |||||
| PPE Net | 10,171,000 | 10,162,000 | 9,031,000 | 8,849,000 | 8,917,000 |
| Intangibles | 62,384,000 | 64,185,000 | 31,804,000 | 32,112,000 | 32,792,000 |
| Other Non-Current Assets | 6,564,000 | 6,183,000 | 5,532,000 | 5,230,000 | 5,476,000 |
| TOTAL | $79,119,000 | $80,530,000 | $46,367,000 | $46,191,000 | $47,185,000 |
| Total Assets | $105,363,000 | $107,221,000 | $73,641,000 | $64,926,000 | $66,729,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,660,000 | 2,744,000 | 2,696,000 | 2,042,000 | 2,194,000 |
| Accounts payable and accrued liabilities | 2,824,000 | 18,663,000 | 17,729,000 | 17,370,000 | 2,350,000 |
| TOTAL | $22,594,000 | $23,649,000 | $22,222,000 | $21,513,000 | $20,307,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,134,000 | 28,206,000 | 24,109,000 | 17,410,000 | 17,505,000 |
| Other Non-Current Liabilities | 8,343,000 | 8,153,000 | 8,181,000 | 8,254,000 | 9,818,000 |
| TOTAL | $43,482,000 | $43,660,000 | $35,726,000 | $28,967,000 | $30,784,000 |
| Total Liabilities | $66,076,000 | $67,309,000 | $57,948,000 | $50,480,000 | $51,091,000 |
| Shareholders' Equity | |||||
| Common Shares | 387,000 | 387,000 | 328,000 | 328,000 | 328,000 |
| Retained earnings | 1,710,000 | 2,200,000 | 5,335,000 | 4,089,000 | 5,299,000 |
| Other shareholders' equity | 1,892,000 | 2,039,000 | 2,033,000 | 2,037,000 | 1,871,000 |
| TOTAL | $39,268,000 | $39,744,000 | $15,676,000 | $14,430,000 | $15,622,000 |
| Total Liabilities And Equity | $105,344,000 | $107,053,000 | $73,624,000 | $64,910,000 | $66,713,000 |